Chinese Stocks To Add to Your Watchlist - November 10th
Diageo, UP Fintech, and Regencell Bioscience are highlighted as key Chinese stocks to watch according to MarketBeat. Diageo is a major alcoholic beverage producer, UP Fintech offers online brokerage services for Chinese investors, and Regencell focuses on Traditional Chinese medicine for neurocognitive disorders. These companies have shown high trading volumes recently, providing investors with exposure to the Chinese economy, albeit with associated risks.
- Zoom Video Indicates Normalization Ends and Growth Resumes
Diageo, UP Fintech, and Regencell Bioscience are the three Chinese stocks to watch today, according to MarketBeat's stock screener tool. Chinese stocks are equity securities issued by companies that are incorporated in China or whose primary business operations are in China, and they can trade on mainland exchanges (Shanghai, Shenzhen), the Hong Kong Stock Exchange, or abroad via listings such as American Depositary Receipts. For investors, they provide exposure to the Chinese economy but come with specific risks including local regulatory and governance differences, currency fluctuations, and geopolitical factors. These companies had the highest dollar trading volume of any Chinese stocks within the last several days.
Diageo (DEO)
Diageo plc, together with its subsidiaries, engages in the production, marketing, and sale of alcoholic beverages. The company offers scotch, gin, vodka, rum, raki, liqueur, wine, tequila, Chinese white spirits, cachaça, and brandy, as well as beer, including cider and flavored malt beverages. It also provides Chinese, Canadian, Irish, American, and Indian-Made Foreign Liquor whiskies, as well as flavored malt beverages, ready to drink, and non-alcoholic products.
- Modelo Sale Success Propels Constellation Brands In The Market
Read Our Latest Research Report on DEO
UP Fintech (TIGR)
UP Fintech Holding Limited provides online brokerage services focusing on Chinese investors. The company has developed a brokerage platform, which allows investor to trade stocks, options, warrants, and other financial instruments that can be accessed through its APP and website. It offers brokerage and value-added services, including investor education, community engagement, and IR platform services.
- 3 Beer Stocks to Tap into if You're Ready for Some Football
Read Our Latest Research Report on TIGR
Regencell Bioscience (RGC)
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.
Read Our Latest Research Report on RGC
Featured Articles
- MarketBeat's Top Five Stocks to Own in November 2025
- 3 Stocks Showing Relative Strength as Markets Pull Back
- 5 Defensive Consumer Plays to Watch If Markets Keep Slipping
- Analysts Keep Raving Over AppLovin: Targets Rise Post-Earnings
- Is Airbnb Stock a Buy After Q3 Earnings Miss?
- 2 Reasons to Buy Into Lam’s 185% Rally, 1 Reason to Run Away
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Should You Invest $1,000 in Diageo Right Now?
Before you consider Diageo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diageo wasn't on the list.
While Diageo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
